vimarsana.com

Page 9 - ஆயோக் உறுப்பினர் ஆரோக்கியம் டாக்டர் வ்க் பால் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Supporting Moderna for Covid vax to be donated to India: Cipla

Supporting Moderna for Covid vax to be donated to India: Cipla SECTIONS Last Updated: Jun 29, 2021, 11:21 PM IST Share Synopsis Moderna s vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik V. TOI.in India s drug regulator DCGI has granted permission to Cipla to import Moderna s COVID-19 vaccine for restricted emergency use in the country, officials said on Tuesday. Related NEW DELHI: Pharma major Cipla on Tuesday said it is supporting Moderna with the regulatory approval and import of COVID-19 vaccines to be donated to India and there is no agreement on commercial supplies at this stage.

4 61 crore Covid doses given in 8 days: Govt

1128 A health worker inoculates an old woman with Covishield vaccine during a door-to-door vaccination drive, at Chitnan village at Vatora Island in Howrah, on Tuesday, June 29, 2021. PTI New Delhi, June 29 A marked increase in the pace of Covid-19 vaccination has been observed from June 21 with around 4.61 crore doses being administered in eight days, which is more than the population of Iraq (4.02 crore), Canada (3.77 crore), Saudi Arabia (3.48 crore) and Malaysia (3.23 crore), the government said on Tuesday. On an average, 57.68 lakh doses of the vaccine were administered per day which is more than the population of Finland (55.41 lakh), Norway (54.21 lakh) and New Zealand (48.22 lakh), Joint Secretary in the Health Ministry Lav Agarwal said addressing a press conference.

Cipla gets nod to bring Moderna vax to India

Cipla gets nod to bring Moderna vax to India Cipla gets nod to bring Moderna vax to India Agencies / Updated: Jun 30, 2021, 06:00 IST Moderna’s covid-19 vaccine for restricted emergency use in the country, officials said on Tuesday. Moderna’s vaccine will be the fourth covid-19 jab to be available in India after Covishield, Covaxin and Sputnik. An application was received from Moderna through their Indian partner Cipla following which Moderna’s covid-19 vaccine has been granted restricted emergency use authorisation by the drug regulator. “This new permission for restricted emergency use potentially opens up a clear possibility of this vaccine being imported to India in the near future,” NITI Aayog Member (Health) Dr V K Paul said at a press conference.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.